Janet Hammond, M.D., Ph.D., has been appointed vice president of Translational Medicine – Virology in Pharmaceutical Research and Early Development (pRED) at Roche. Dr. Hammond will report to Jacques Banchereau, Ph.D., Discovery and Translational Area (DTA) head for Inflammation and Virology, and chief scientific officer at Nutley. She will be responsible for driving strategy and implementation of early clinical development for the Virology DTA. Dr. Hammond has 13 years of experience in the ...